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Abstract
Body mass index (BMI) is calculated using a person’s weight by the square of their height (kg/m2), and is
used to broadly categorise a person as underweight, normal weight, overweight or obese. This paper will
explore the association of patient characteristics and outcomes by BMI category using data collected by
the electronic Persistent Pain Outcomes Collaboration (ePPOC).
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Summary:
This study aimed to explore sociodemographic profile, clinical characteristics and treatment outcomes by body
mass index (BMI) for individuals who completed an episode of care at an Australian specialist pain service. 43846
adult patients who completed treatment and provided BMI information at referral were included in the analysis.
Patients provided data at referral during the period 2014-2021. The analysis shows:
•
•
•
•
•

Nearly 3 in 4 patients were either in the overweight or obese category. This is higher than the national
estimate which reports two thirds of Australian adults are either overweight or obese.
Obesity was more frequent in people who were born in Australia, did not require an interpreter and/or
identified as Aboriginal or Torres Strait Islander.
There was an increase in obesity from the least to the more disadvantaged socioeconomic areas
Pain severity, interference, depression, anxiety, stress, catastrophising and pain self-efficacy were similar
at referral, regardless of BMI.
While there were some differences in patient reported outcomes by BMI, effect sizes were less than small
despite statistical significance. This suggests that outcomes following treatment were similar, regardless of
BMI at referral.

Publication details
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Background
Body mass index (BMI) is calculated using a person’s weight by the square of their height (kg/m2), and is used to
broadly categorise a person as underweight, normal weight, overweight or obese. This paper will explore the
association of patient characteristics and outcomes by BMI category using data collected by the electronic Persistent
Pain Outcomes Collaboration (ePPOC).
ePPOC is an Australasian initiative that aims to improve the quality of care and outcomes for people who experience
chronic pain. ePPOC works with Australian and New Zealand pain services to improve the quality of care and
outcomes for people with chronic pain through the collection of non-identifiable data related to patients and their
care. The data are then analysed and benchmarked to highlight areas for quality improvement to services.
Furthermore, ePPOC promotes research into areas of importance in pain management. Further details regarding the
establishment of ePPOC and the data collected can be found in Tardif et al 1 and at
https://www.uow.edu.au/ahsri/eppoc/.

Aims
This study aimed to explore the sociodemographic profile, clinical characteristics and treatment outcomes for patients
as a function of BMI. It focusses on patients seeking care in Australian pain services, with a separate paper addressing
results in New Zealand pain services (Information Series No.2 2022).

Methods
The data included in the analysis were provided by Australian persistent pain management services participating in
ePPOC. The inclusion criteria were:
•
•
•
•

Adult patients aged 18 years and above at referral
Completion of patient-rated information at referral during the period January 2014 - December 2021
Completion of an episode of pain management at an Australian specialist pain service or Primary Health
Network
Completion of the Weight and Height variables to allow calculation of BMI

Frequencies and percentages were used to explore patients’ sociodemographic profile, clinical characteristics and
treatment outcome by BMI. We used Chi-squared tests to observe the association of BMI categories with patient
characteristics for categorical variables and Kruskal-Wallis tests to test the relationship of age and pain assessment
scores at referral by BMI category. Effect sizes were measured using Cramer’s V to assess the degree or magnitude of
associations between categorical variables and BMI. Cramer’s V values range from 0 to 1, and are categorised as small
(0.06 – 0.17), moderate (0.17 – 0.29 and high (> 0.29)2. The effect size for Kruskal-Wallis tests was computed using eta
squared3, with the value interpreted as a small (0.01 – 0.06), moderate (0.06 – 0.14) and large (> 0.14) effect.

1

Tardif, H., et al., Establishment of the Australasian electronic persistent pain outcomes collaboration. Pain Medicine,
2017. 18(6): p. 1007-1018
2
Kim, H.-Y., Statistical notes for clinical researchers: Chi-squared test and Fisher's exact test. Restorative dentistry &
endodontics, 2017. 42(2): p. 152-155.
3
Tomczak M, Tomczak E. The need to report effect size estimates revisited. An overview of some recommended
measures of effect size. Trends in sport sciences. 2014 Jul;1(21):19-25.
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Results
Data relating to 43846 patients were included. Of these patients, 948 (2.2%), 11368 (25.9%), 13328 (30.4%) and 18202
(41.5%) were classified as underweight, healthy weight, overweight and obese, respectively. The proportion of
patients in the overweight or obese category (71.9%) is higher than the Australia national estimate, which reported
that two thirds (67.0%) of Australian adults were overweight or obese4. The characteristics of the group by BMI
category are shown in Figures 1 and 2, and detailed in Tables A1 and A2 in the Appendix. As the underweight category
is relatively small, comparisons focus on the differences between the healthy weight and overweight/obese groups.
Obese and overweight patients were older than healthy weight patients, at 52 vs. 49 years of age (see Table A1).
Males were less likely to be in the healthy weight range, although a higher proportion of females were obese (44% vs.
39% of males). People who were born in Australia, did not require an interpreter and/or those identifying as
Aboriginal or Torres Strait Islander were less likely to be of healthy weight and more likely to be obese. There was a
decrease in the proportion of people in the healthy weight range and an increase in obesity from the least to the more
disadvantaged socioeconomic areas 5.
Figure 1: Distribution of BMI categories by sociodemographic characteristics
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https://www.abs.gov.au/statistics/health/health-conditions-and-risks/overweight-and-obesity/latest-release
https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/2033.0.55.001~2016~Main%20Features~IRSD~19
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Figure 2: Distribution of BMI category by referral source and other clinical characteristics
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Figure 2 depicts the relationship between BMI and the presence of a hearing or sight impairment, pain duration,
referral source and main pain region. Most notably, longer pain duration was associated with a decrease in the
proportion of healthy weight individuals and an increase in obesity. For example, obesity was reported in 45% of
patients whose pain duration was more than 5 years, and 30% in those who had experienced their pain for less than 3
months.
Table 1 shows medication use and comorbidities at referral by BMI category. Patients who were obese and
overweight were somewhat more likely to use medications containing opioids, paracetamol, antidepressants, NSAIDs
and anticonvulsants compared to those in the healthy weight range. The prevalence of comorbidities was also greater,
particularly in the obese group, with a higher proportion reporting mental health conditions, arthritis, heart and
circulation problems, high blood pressure, diabetes, and digestive and respiratory problems. The prevalence of living
with three or more comorbidities was 46% in patients who were obese compared to 27% in those of a healthy weight.
Table 1: Medication use and comorbidities by BMI category
Body Mass Index (BMI) classification
Underweight

Healthy
weight

Overweight

Obese

Total

257 (61.2)
170 (40.5)
167 (39.8)
113 (26.9)
122 (29.0)
96 (22.9)
1 (0.2)

3066 (56.5)
2692 (49.6)
2147 (39.5)
1780 (32.8)
1625 (29.9)
927 (17.1)
55 (1.0)

3999 (59.5)
3398 (50.5)
2836 (42.2)
2228 (33.1)
2180 (32.4)
1017 (15.1)
54 (0.8)

6033 (62.8)
5136 (53.5)
4590 (47.8)
3303 (34.4)
3317 (34.5)
1438 (15.0)
53 (0.6)

13355 (60.2)
11396 (51.4)
9740 (43.9)
7424 (33.5)
7244 (32.7)
3478 (15.7)
163 (0.7)

457 (48.2)
274 (28.9)
173 (18.2)
213 (22.5)

5050 (44.4)
3205 (28.2)
2006 (17.6)
1948 (17.1)

5878 (44.1)
4248 (31.9)
3269 (24.5)
2352 (17.6)

9277 (51.0)
7441 (40.9)
6221 (34.2)
4132 (22.7)

20662 (47.1)
15168 (34.6)
11669 (26.6)
8645 (19.7)

220 (25.4)

2231 (21.1)

2684 (21.6)

4217 (24.7)

9352 (22.9)

178 (18.8)
70 (7.4)
32 (3.4)
72 (7.6)
61 ( 6.4)
56 ( 5.9)
32 (3.7)
184 (19.4)

1444 (12.7)
1152 (10.1)
449 (4.0)
750 (6.6)
508 (4.5)
496 (4.4)
465 (4.4)
1710 (15.0)

1768 (13.3)
2258 (16.9)
855 (6.4)
888 (6.7)
678 (5.1)
560 (4.2)
574 (4.6)
1947 (14.6)

3881 (21.3)
4710 (25.9)
2404 (13.2)
1285 ( 7.1)
1231 ( 6.8)
766 ( 4.2)
1166 (6.8)
3040 (16.7)

7271 (16.6)
8190 (18.7)
3740 (8.5)
2995 (6.8)
2478 (5.7)
1878 (4.3)
2237 (5.5)
6881 (15.7)

209 (22.1)
241 (25.4)
199 (21.0)
299 (31.5)

2943 (25.9)
3279 (28.8)
2130 (18.7)
3016 (26.5)

3140 (23.6)
3336 (25.0)
2507 (18.8)
4345 (32.6)

2777 (15.3)
3736 (20.5)
3412 (18.8)
8277 (45.5)

9069 (20.7)
10592 (24.2)
8248 (18.8)
15937 (36.4)

Medication use at referral, n(%)
Opioid
Paracetamol
Antidepressant
NSAID
Anticonvulsant
Sedatives
Medicinal cannabinoids
Comorbidities, n(%)
Mental Health condition
Arthritis
Heart and circulation
Digestive problems
Muscle, bone and joint
problems
Respiratory problems
High blood pressure
Diabetes
Neurological problems
Liver, kidney and pancreas
Cancer
Thyroid
Other medical problems
Number of co-morbidities, n(%)
0
1
2
3 or more

NSAID: Non-steroidal anti-inflammatory medication
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Scores at referral on each of the assessment tools are shown in Table 2. These scores reflect increasing symptom
severity from the healthy weight range to the overweight and obese categories. Whilst this information suggests that
people in the healthy weight range tend to have less severe symptoms at referral, it should be noted that the
differences between groups (the effect size) are classified as being less than small and, as such, are unlikely to be
clinically significant.
Table 2: Mean scores on the patient-reported assessment tools at referral, by BMI category
Body Mass Index (BMI) classification
Assessment tool
Pain severity
Pain interference
Depression
Anxiety
Stress
Pain catastrophising
Pain self-efficacy

Underweight
6.3
7.1
20.6
15.0
21.3
29.8
20.2

Healthy
weight
6.1
6.8
19.1
13.1
20.4
28.2
22.0

Overweight
6.2
6.9
19.5
13.1
20.6
28.5
21.4

Obese

Total

6.3
7.2
21.0
14.5
21.2
29.4
19.6

6.3
7.0
20.1
13.9
20.9
29.1
20.8

Effect
size
0.003
0.010
0.004
0.005
0.001
0.001
0.006

Effect size
description
< small
< small
< small
< small
< small
< small
< small

Note: ‘< small’ indicates the effect size is less than small. Higher PSEQ indicates less impairment.

Patient outcomes at the end of the episode are shown in the following Tables. Table 3 shows the proportion of
patients reporting clinically significant improvement on each domain measured by the standardised assessment tools
(for patients reporting at least a moderate level of symptom at referral). Approximately one in four reported clinically
significant improvement in their pain and a large proportion reported improvements across the other clinical domains.
Table 3: Patients reporting clinically significant improvement at episode end, by BMI category
Body Mass Index (BMI) classification
Assessment tool, n(%)
Pain severity
Pain interference
Depression
Anxiety
Stress
Pain catastrophising
Pain self-efficacy

Underweight
44 (27.3)

Healthy
weight
744 (26.0)

Overweight
871 (24.6)

115 (65.3)
65 (57.0)
52 (40.6)
65 (62.5)
89 (64.0)
75 (51.0)

1865 (61.2)
1206 (55.7)
815 (43.1)
1066 (58.1)
1339 (56.2)
1326 (50.0)

2296 (59.7)
1539 (54.5)
1013 (41.5)
1315 (55.3)
1601 (52.5)
1591 (46.2)

Obese

Total

Effect size

1084 (22.5)
3057 (58.2)
2060 (53.1)
1384 (40.0)
1750 (54.8)
2176 (53.3)
2218 (46.8)

2743 (24.1)
7333 (59.5)
4870 (54.2)
3264 (41.2)
4196 (55.9)
5205 (53.9)
5210 (47.4)

0.034
0.029
0.022
0.025
0.031
0.038
0.031

Effect size
description
< small

< small
< small
< small
< small
< small
< small

< small indicates the effect size is less than small

Table 4 shows scores on the Global Rating of Change, which measures the patient’s perception of change (both overall
and in respect to physical functioning) compared to before receiving treatment at the pain service. At the end of the
episode, around 70% of all patients reported making at least some overall improvement, and 67% reported some
improvement in their physical abilities.
A comparison of outcomes across the BMI groups suggests that overweight and obese patients are less likely to
report clinically significant improvement or provide positive ratings of change. However, the size of the differences
between BMI categories is less than small, and hence, unlikely to be clinically important.
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Table 4: Global rating of change scores, by BMI category
Body Mass Index (BMI) classification

GRC – overall, n (%)
3 (very much better)
2
1
0 (no change)
-1
-2
-3 (very much worse)
GRC – physical, n (%)
3 (very much better)
2
1
0 (no change)
-1
-2
-3 (very much worse)

Underweight

Healthy
weight

Overweight

Obese

Total

Effect size

Effect size
description

11 (8.7)
37 (29.1)
37 (29.1)
16 (12.6)
8 (6.3)
7 (5.5)
11 (8.7)

248 (11.0)
601 (26.7)
763 (33.9)
418 (18.5)
103 (4.6)
79 (3.5)
42 (1.9)

295 (10.3)
802 (28.0)
931 (32.5)
547 (19.1)
124 ( 4.3)
97 ( 3.4)
67 ( 2.3)

408 (10.6)
1051 (27.2)
1204 (31.2)
767 (19.9)
176 ( 4.6)
150 ( 3.9)
102 ( 2.6)

962 (10.6)
2491 (27.4)
2935 (32.3)
1748 (19.2)
411 (4.5)
333 (3.7)
222 (2.4)

0.037

< small

10 (7.9)
33 (26.2)
30 (23.8)
29 (23.0)
6 (4.8)
8 (6.3)
10 (7.9)

195 (8.7)
592 (26.4)
742 (33.1)
539 (24.0)
82 ( 3.7)
60 ( 2.7)
34 ( 1.5)

242 ( 8.5)
701 (24.5)
980 (34.3)
676 (23.7)
117 (4.1)
90 (3.2)
50 (1.8)

342 ( 8.9)
947 (24.6)
1276 (33.2)
865 (22.5)
167 (4.3)
158 (4.1)
94 (2.4)

789 (8.7)
2273 (25.1)
3028 (33.4)
2109 (23.2)
372 (4.1)
316 (3.5)
188 (2.1)

0.043

< small
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Appendix
Table A1: Sociodemographic characteristics by BMI category for patients who attended a pain management
service in Australia (2014-2021)
Body Mass Index (BMI) classification
Characteristics

Underweight

Healthy
weight

Overweight

Obese

Total

Age, mean (sd)

46.9 (17.1)

48.5 (15.9)

51.5 (15.2)

51.8 (14.1)

51.5 (15.3)

Male

258 (1.4)

4501 (23.7)

6856 (36.0)

7410 (38.9)

19025 (43.5)

Female

684 (2.8)

6849 (27.7)

6445 (26.0)

10764 (43.5)

24742 (56.5)

Aboriginal or Torres Strait Islander, n(%)
Yes
26 (1.7)

308 (20.7)

351 (23.6)

801 (53.9)

1486 (3.6)

873 (2.2)

10438 (26.0)

12353 (30.7)

16545 (41.1)

40209 (96.4)

No

893 (2.2)

10624 (25.7)

12497 (30.2)

17311 (41.9)

41325 (95.9)

Yes

37 (2.1)

540 (30.2)

624 (34.8)

590 (32.9)

1791 (4.1)

Australia

686 (2.3)

7565 (25.0)

8786 (29.0)

13263 (43.8)

30300 (70.5)

Other

242 (1.9)

3555 (28.1)

4269 (33.7)

4597 (36.3)

12663 (29.5)

2797 (32.9)

2735 (32.2)

2740 (32.3)

8491 (20.5)

Sex, n(%)

No
Interpreter required, n(%)

Country of birth, n(%)

6

Socioeconomic disadvantage quintile , n(%)
1 – least
219 (2.6)
2

160 (2.2)

1962 (27.0)

2220 (30.6)

2914 (40.2)

7256 (17.6)

3

217 (2.1)

2362 (23.1)

3108 (30.4)

4525 (44.3)

10212 (24.7)

4

166 (2.2)

1775 (23.6)

2167 (28.8)

3426 (45.5)

7534 (18.2)

5 – most

137 (1.7)

1844 (23.5)

2279 (29.0)

3589 (45.7)

7849 (19)

6

Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016 LATEST ISSUE Released at 11:30 AM
(CANBERRA TIME) 27/03/2018.
https://www.abs.gov.au/Ausstats/abs@.nsf/0/4E5531D7B85288A9CA2577E4000E1F9E?OpenDocument
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Table A2: Hearing or sight impairment, pain duration, referral source and main pain area by BMI category for
patients who attended pain management service in Australia (2014-2021)
Body Mass Index (BMI) classification
Characteristics

Underweight

Healthy
weight

Overweight

Obese

Total

Hearing or sight impaired?, n(%)
No

797 (2.2)

9757 (26.5)

11268 (30.6)

14997 (40.7)

36819 (85.8)

Yes

130 (2.1)

1349 (22.2)

1798 (29.5)

2813 (46.2)

6090 (14.2)

less than 3 months

22 (2.7)

293 (35.9)

257 (31.5)

245 (30.0)

817 (1.9)

3 months to 12 months

152 (2.6)

1724 (29.5)

1802 (30.9)

2163 (37.0)

5841 (13.7)

12 months to 2 years

127 (1.9)

1788 (26.8)

2170 (32.5)

2592 (38.8)

6677 (15.6)

2-5 years

199 (2.0)

2623 (26.0)

3149 (31.2)

4107 (40.8)

10078 (23.8)

More than 5 years

417 (2.2)

4560 (24.0)

5531 (29.1)

8480 (44.7)

18988 (44.8)

GP/nurse practitioner

657 (2.3)

7466 (25.7)

8681 (29.9)

12251 (42.2)

29055 (66.3)

Specialist practitioner
Other pain management
service
Public hospital

167 (1.7)

2702 (26.7)

3278 (32.4)

3972 (39.3)

10119 (23.1)

4 (1.1)

80 (22.2)

115 (31.9)

161 (44.7)

360 (0.8)

106 (3.0)

907 (25.9)

1008 (28.8)

1485 (42.4)

3506 (8)

Private hospital
Rehabilitation
provider/private insurer
Other

3 (3.7)

28 (34.1)

25 (30.5)

26 (31.7)

82 (0.2)

2 (1.7)

30 (25.0)

36 (30.0)

52 (43.3)

120 (0.3)

9 (1.5)

155 (25.7)

185 (30.6)

255 (42.2)

604 (1.4)

Abdomen

215 (3.9)

1583 (28.7)

1525 (27.7)

2190 (39.7)

5513 (12.9)

Arm/shoulder

445 (2.2)

5257 (25.9)

6032 (29.7)

8557 (42.2)

20291 (47.1)

Back

563 (2.1)

6556 (24.9)

7920 (30.0)

11330 (43.0)

26369 (61.0)

Chest

141 (3.1)

1260 (28.1)

1276 (28.5)

1806 (40.3)

4483 (10.5)

Feet

282 (1.9)

3348 (22.7)

4293 (29.1)

6815 (46.2)

14738 (34.3)

Hands

216 (2.0)

2596 (24.6)

3026 (28.7)

4715 (44.7)

10553 (24.6)

Head

210 (2.7)

2141 (27.7)

2281 (29.5)

3091 (40.0)

7723 (18.0)

Hips

454 (2.2)

5065 (24.3)

6069 (29.2)

9230 (44.3)

20818 (48.2)

Knee

429 (2.1)

4593 (22.7)

5774 (28.5)

9475 (46.7)

20271 (46.8)

Leg

432 (1.9)

5359 (23.3)

6788 (29.6)

10380 (45.2)

22959 (53.2)

Neck

359 (2.2)

4345 (27.0)

4804 (29.9)

6563 (40.8)

16071 (37.4)

Pelvic and/or genital

124 (2.7)

1226 (26.5)

1322 (28.6)

1950 (42.2)

4622 (10.8)

Pain duration, n(%)

Referral source, n(%)

Main pain, n(%)
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